Clearmind Medicine Inc.

CMND | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.78

-$0.01 (-1.34%)

Sep 22, 2026, 1:56 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.34%

(1D)

Rating

Updated: Aug 29, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.16M

1D Range

0.77 0.79

52W Range

0.77 480

Valuation (TTM)

PE -0.07

PB 0.09

EV/EBITDA 1.57

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -641.8%

SBC Adj. FCF Yield -776.0%

SBC Impact -20.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 92.8% | 80.4%

FCF 3Y | 5Y -12.9% | -10.3%

Returns

ROA -44.3%

ROE -87.3%

ROIC -60.1%

Financial Health

Net Cash

$14.23M

Current Ratio 4.31

Interest Coverage -649.82

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental ...

Sector Healthcare

Industry Biotechnology

Employees 4

IPO Date Nov 14, 2022

Website www.clearmindmedicine.com

Fiscal Year November - October

Full Company Profile

Latest News

No news articles available yet.